Negative association between the chemokine receptor CCR5-Δ32 polymorphism and rheumatoid arthritis: a meta-analysis (original) (raw)

References

  1. Jawaheer D, Gregersen PK . The search for rheumatoid arthritis susceptibility genes: a call for global collaboration. Arthritis Rheum 2002; 46: 582–584.
    Article PubMed Google Scholar
  2. Lohmueller KE, Pearce CL, Pike M, Lander ES, Hirschhorn JN . Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat Genet 2003; 33: 177–182.
    Article CAS PubMed Google Scholar
  3. Loetscher P, Uguccioni M, Bordoli L, Baggiolini M, Moser B, Chizzolini C et al. CCR5 is characteristic of Th1 lymphocytes. Nature 1998; 391: 344–345.
    Article CAS PubMed Google Scholar
  4. Qin S, Rottman JB, Myers P, Kassam N, Weinblatt M, Loetscher M et al. The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. J Clin Invest 1998; 101: 746–754.
    Article CAS PubMed PubMed Central Google Scholar
  5. Suzuki N, Nakajima A, Yoshino S, Matsushima K, Yagita H, Okumura K . Selective accumulation of CCR5+ T lymphocytes into inflamed joints of rheumatoid arthritis. Int Immunol 1999; 11: 553–559.
    Article CAS PubMed Google Scholar
  6. Ruth JH, Rottman JB, Katschke Jr KJ, Qin S, Wu L, LaRosa G et al. Selective lymphocyte chemokine receptor expression in the rheumatoid joint. Arthritis Rheum 2001; 44: 2750–2760.
    Article CAS PubMed Google Scholar
  7. Katschke Jr KJ, Rottman JB, Ruth JH, Qin S, Wu L, LaRosa G et al. Differential expression of chemokine receptors on peripheral blood, synovial fluid, and synovial tissue monocytes/macrophages in rheumatoid arthritis. Arthritis Rheum 2001; 44: 1022–1032.
    Article CAS PubMed Google Scholar
  8. Robinson E, Keystone EC, Schall TJ, Gillett N, Fish EN . Chemokine expression in rheumatoid arthritis (RA): evidence of RANTES and macrophage inflammatory protein (MIP)-1 beta production by synovial T cells. Clin Exp Immunol 1995; 101: 398–407.
    Article CAS PubMed PubMed Central Google Scholar
  9. Koch AE, Kunkel SL, Harlow LA, Mazarakis DD, Haines GK, Burdick MD et al. Macrophage inflammatory protein-1 alpha. A novel chemotactic cytokine for macrophages in rheumatoid arthritis. J Clin Invest 1994; 93: 921–928.
    Article CAS PubMed PubMed Central Google Scholar
  10. Liu R, Paxton WA, Choe S, Ceradini D, Martin SR, Horuk R et al. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 1996; 86: 367–377.
    Article CAS PubMed Google Scholar
  11. Samson M, Libert F, Doranz BJ, Rucker J, Liesnard C, Farber CM et al. Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 1996; 382: 722–725.
    Article CAS PubMed Google Scholar
  12. Garred P, Madsen HO, Petersen J, Marquart H, Hansen TM, Freiesleben Sorensen S et al. CC chemokine receptor 5 polymorphism in rheumatoid arthritis. J Rheumatol 1998; 25: 1462–1465.
    CAS PubMed Google Scholar
  13. Gomez-Reino JJ, Pablos JL, Carreira PE, Santiago B, Serrano L, Vicario JL et al. Association of rheumatoid arthritis with a functional chemokine receptor, CCR5. Arthritis Rheum 1999; 42: 989–992.
    Article CAS PubMed Google Scholar
  14. Pokorny V, McQueen F, Yeoman S, Merriman M, Merriman A, Harrison A et al. Evidence for negative association of the chemokine receptor CCR5 d32 polymorphism with rheumatoid arthritis. Ann Rheum Dis 2005; 64: 487–490.
    Article CAS PubMed Google Scholar
  15. Zapico I, Coto E, Rodriguez A, Alvarez C, Torre JC, Alvarez V . CCR5 (chemokine receptor-5) DNA-polymorphism influences the severity of rheumatoid arthritis. Genes Immun 2000; 1: 288–289.
    Article CAS PubMed Google Scholar
  16. Cooke SP, Forrest G, Venables PJ, Hajeer A . The delta32 deletion of CCR5 receptor in rheumatoid arthritis. Arthritis Rheum 1998; 41: 1135–1136.
    Article CAS PubMed Google Scholar
  17. John S, Smith S, Morrison JF, Symmons D, Worthington J, Silman A et al. Genetic variation in CCR5 does not predict clinical outcome in inflammatory arthritis. Arthritis Rheum 2003; 48: 3615–3616.
    Article PubMed Google Scholar
  18. Venables PJ, Hajeer A . Delta32CCR5 and rheumatoid arthritis: comment on the article by Gomez-Reino et al. Arthritis Rheum 1999; 42: 2732–2733.
    Article CAS PubMed Google Scholar
  19. Mack M, Bruhl H, Gruber R, Jaeger C, Cihak J, Eiter V et al. Predominance of mononuclear cells expressing the chemokine receptor CCR5 in synovial effusions of patients with different forms of arthritis. Arthritis Rheum 1999; 42: 981–988.
    Article CAS PubMed Google Scholar
  20. Zuniga JA, Villarreal-Garza C, Flores E, Barquera R, Perez-Hernandez N, Montes de Oca JV et al. Biological relevance of the polymorphism in the CCR5 gene in refractory and non-refractory rheumatoid arthritis in Mexicans. Clin Exp Rheumatol 2003; 21: 351–354.
    CAS PubMed Google Scholar
  21. Bakhiet M, Tjernlund A, Mousa A, Gad A, Stromblad S, Kuziel WA et al. RANTES promotes growth and survival of human first-trimester forebrain astrocytes. Nat Cell Biol 2001; 3: 150–157.
    Article CAS PubMed Google Scholar
  22. Gonzalez E, Bamshad M, Sato N, Mummidi S, Dhanda R, Catano G et al. Race-specific HIV-1 disease-modifying effects associated with CCR5 haplotypes. Proc Natl Acad Sci USA 1999; 96: 12004–12009.
    Article CAS PubMed PubMed Central Google Scholar
  23. Bamshad MJ, Mummidi S, Gonzalez E, Ahuja SS, Dunn DM, Watkins WS et al. A strong signature of balancing selection in the 5' _cis_-regulatory region of CCR5. Proc Natl Acad Sci USA 2002; 99: 10539–10544.
    Article CAS PubMed PubMed Central Google Scholar
  24. Mummidi S, Bamshad M, Ahuja SS, Gonzalez E, Feuillet PM, Begum K et al. Evolution of human and non-human primate CC chemokine receptor 5 gene and mRNA. Potential roles for haplotype and mRNA diversity, differential haplotype-specific transcriptional activity, and altered transcription factor binding to polymorphic nucleotides in the pathogenesis of HIV-1 and simian immunodeficiency virus. J Biol Chem 2000; 275: 18946–18961.
    Article CAS PubMed Google Scholar
  25. Little J, Bradley L, Bray MS, Clyne M, Dorman J, Ellsworth DL et al. Reporting, appraising, and integrating data on genotype prevalence and gene-disease associations. Am J Epidemiol 2002; 156: 300–310.
    Article PubMed Google Scholar
  26. Easterbrook PJ, Berlin JA, Gopalan R, Matthews DR . Publication bias in clinical research. Lancet 1991; 337: 867–872.
    Article CAS PubMed Google Scholar
  27. Plater-Zyberk C, Hoogewerf AJ, Proudfoot AE, Power CA, Wells TN . Effect of a CC chemokine receptor antagonist on collagen induced arthritis in DBA/1 mice. Immunol Lett 1997; 57: 117–120.
    Article CAS PubMed Google Scholar
  28. Yang YF, Mukai T, Gao P, Yamaguchi N, Ono S, Iwaki H et al. A non-peptide CCR5 antagonist inhibits collagen-induced arthritis by modulating T cell migration without affecting anti-collagen T cell responses. Eur J Immunol 2002; 32: 2124–2132.
    Article CAS PubMed Google Scholar

Download references